Patents by Inventor Inna SOLOMONOV

Inna SOLOMONOV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240041992
    Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
    Type: Application
    Filed: October 9, 2023
    Publication date: February 8, 2024
    Applicant: NanoCell Ltd.
    Inventors: Irit SAGI, Inna SOLOMONOV, Eldar ZEHORAI
  • Patent number: 11779636
    Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
    Type: Grant
    Filed: July 7, 2022
    Date of Patent: October 10, 2023
    Assignee: NanoCell Ltd.
    Inventors: Irit Sagi, Inna Solomonov, Eldar Zehorai
  • Publication number: 20220347274
    Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
    Type: Application
    Filed: July 7, 2022
    Publication date: November 3, 2022
    Applicant: NanoCell Ltd.
    Inventors: Irit SAGI, Inna SOLOMONOV, Eldar ZEHORAI
  • Patent number: 11400156
    Abstract: A method of treating or preventing a disease associated with a secondary infection in a subject infected with a pathogen is provided. The method comprises administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards the pathogen and a therapeutically effective amount of an agent which down-regulates at least one extracellular matrix-associated polypeptide.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: August 2, 2022
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Irit Sagi, Dalit Talmi-Frank, Inna Solomonov, Ido Amit
  • Patent number: 11382959
    Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: July 12, 2022
    Assignee: NanoCell Ltd.
    Inventors: Irit Sagi, Inna Solomonov, Eldar Zehorai
  • Publication number: 20210015907
    Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
    Type: Application
    Filed: June 17, 2020
    Publication date: January 21, 2021
    Applicant: NanoCell Ltd.
    Inventors: Irit SAGI, Inna SOLOMONOV, Eldar ZEHORAI
  • Publication number: 20200261577
    Abstract: A method of treating or preventing a disease associated with a secondary infection in a subject infected with a pathogen is provided. The method comprises administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards the pathogen and a therapeutically effective amount of an agent which down-regulates at least one extracellular matrix-associated polypeptide.
    Type: Application
    Filed: March 26, 2020
    Publication date: August 20, 2020
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Irit SAGI, Dalit TALMI-FRANK, Inna SOLOMONOV, Ido AMIT
  • Patent number: 10722560
    Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: July 28, 2020
    Assignee: NanoCell Ltd.
    Inventors: Irit Sagi, Inna Solomonov, Eldar Zehorai
  • Patent number: 10610588
    Abstract: A method of treating or preventing a disease associated with a secondary infection in a subject infected with a pathogen is provided. The method comprises administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards the pathogen and a therapeutically effective amount of an agent which down-regulates at least one extracellular matrix-associated polypeptide.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: April 7, 2020
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Irit Sagi, Dalit Talmi-Frank, Inna Solomonov, Ido Amit
  • Publication number: 20180133293
    Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
    Type: Application
    Filed: April 1, 2016
    Publication date: May 17, 2018
    Inventors: Irit SAGI, Inna SOLOMONOV, Eldar ZEHORAI
  • Publication number: 20180028650
    Abstract: A method of treating or preventing a disease associated with a secondary infection in a subject infected with a pathogen is provided. The method comprises administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards the pathogen and a therapeutically effective amount of an agent which down-regulates at least one extracellular matrix-associated polypeptide.
    Type: Application
    Filed: February 9, 2016
    Publication date: February 1, 2018
    Inventors: Irit SAGI, Dalit TALMI - FRANK, Inna SOLOMONOV, Ido AMIT